CX3CR1 deficiency delays acute skeletal muscle injury repair by impairing macrophage functions

FASEB Journal

Volumn 30, Issue 1, 2016, Pages 380-393

  Zhao, Wanming ^a   Lu, Haiyan ^b   Wang, Xingyu ^a   Ransohoff, Richard M ^b   Zhou, Lan ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chemokine; IGF 1; Monocyte recruitment; Muscle regeneration; Phagocytosis

Indexed keywords

CD14 ANTIGEN; CD36 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; INTERLEUKIN 6; MESSENGER RNA; SOMATOMEDIN C; CHEMOKINE RECEPTOR; CX3CR1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL COUNT; CELL FUNCTION; CONTROLLED STUDY; GENE EXPRESSION; INTRAMUSCULAR MACROPHAGE; MACROPHAGE; MACROPHAGE FUNCTION; MONOCYTE; MOUSE; MOUSE MODEL; MUSCLE NECROSIS; MUSCLE REGENERATION; MUSCLE TISSUE; MUSCULOSKELETAL INJURY; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SKELETAL MUSCLE CELL; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; DEFICIENCY; GENETICS; INJURIES; METABOLISM; PHYSIOLOGY; REGENERATION; SKELETAL MUSCLE;

ANIMALS; ANTIGENS, CD36; CELLS, CULTURED; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; MACROPHAGES; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; PHAGOCYTOSIS; RECEPTORS, CHEMOKINE; REGENERATION;

EID: 84974816702     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-270090     Document Type: Article

References (51)

1. Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N., Plonquet, A., Gherardi, R. K., and Chazaud, B. (2007) Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204, 1057-1069
2. Contreras-Shannon, V., Ochoa, O., Reyes-Reyna, S. M., Sun, D., Michalek, J. E., Kuziel, W. A., McManus, L. M., and Shireman, P. K. (2007) Fat accumulation with altered inflammation and regeneration in skeletal muscle of CCR2-/- mice following ischemic injury. Am. J. Physiol. Cell Physiol. 292, C953-C967
3. Lu, H., Huang, D., Saederup, N., Charo, I. F., Ransohoff, R. M., and Zhou, L. (2011) Macrophages recruited via CCR2 produce insulin-like growth factor-1 to repair acute skeletal muscle injury. FASEB J. 25, 358-369
4. Sun, D., Martinez, C. O., Ochoa, O., Ruiz-Willhite, L., Bonilla, J. R., Centonze, V. E., Waite, L. L., Michalek, J. E., McManus, L. M., and Shireman, P. K. (2009) Bone marrow-derived cell regulation of skeletal muscle regeneration. FASEB J. 23, 382-395
5. Tidball, J. G. (2005) Inflammatory processes in muscle injury and repair. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R345-R353
6. Wang, H., Melton, D. W., Porter, L., Sarwar, Z. U., McManus, L. M., and Shireman, P. K. (2014) Altered macrophage phenotype transition impairs skeletal muscle regeneration. Am. J. Pathol. 184, 1167-1184
7. Mann, C. J., Perdiguero, E., Kharraz, Y., Aguilar, S., Pessina, P., Serrano, A. L., and Muñoz-Cánoves, P. (2011) Aberrant repair and fibrosis development in skeletal muscle. Skelet. Muscle 1, 1-21
8. Geissmann, F., Jung, S., and Littman, D. R. (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82
9. Lu, H., Huang, D., Ransohoff, R. M., and Zhou, L. (2011) Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB J. 25, 3344-3355
10. Auffray, C., Fogg, D., Garfa, M., Elain, G., Join-Lambert, O., Kayal, S., Sarnacki, S., Cumano, A., Lauvau, G., and Geissmann, F. (2007) Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317, 666-670
11. Landsman, L., Bar-On, L., Zernecke, A., Kim, K. W., Krauthgamer, R., Shagdarsuren, E., Lira, S. A., Weissman, I. L., Weber, C., and Jung, S. (2009) CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 113, 963-972
12. Clover, A. J., Kumar, A. H., and Caplice, N. M. (2011) Deficiency of CX3CR1 delays burn wound healing and is associated with reduced myeloid cell recruitment and decreased sub-dermal angiogenesis. Burns 37, 1386-1393
13. Dénes, A., Ferenczi, S., Halász, J., Környei, Z., and Kovács, K. J. (2008) Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J. Cereb. Blood Flow Metab. 28, 1707-1721
14. Donnelly, D. J., Longbrake, E. E., Shawler, T. M., Kigerl, K. A., Lai, W., Tovar, C. A., Ransohoff, R. M., and Popovich, P. G. (2011) Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages. J. Neurosci. 31, 9910-9922
15. Ishida, Y., Gao, J. L., and Murphy, P. M. (2008) Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J. Immunol. 180, 569-579
16. Ishida, Y., Hayashi, T., Goto, T., Kimura, A., Akimoto, S., Mukaida, N., and Kondo, T. (2008) Essential involvement of CX3CR1-mediated signals in the bactericidal host defense during septic peritonitis. J. Immunol. 181, 4208-4218
17. Kostadinova, F. I., Baba, T., Ishida, Y., Kondo, T., Popivanova, B. K., and Mukaida, N. (2010) Crucial involvement of the CX3CR1-CX3CL1 axis in dextran sulfate sodium-mediated acute colitis in mice. J. Leukoc. Biol. 88, 133-143
18. Cybulsky, M. I., and Hegele, R. A. (2003) The fractalkine receptor CX3CR1 is a key mediator of atherogenesis. J. Clin. Invest. 111, 1118-1120
19. Lesnik, P., Haskell, C. A., and Charo, I. F. (2003) Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J. Clin. Invest. 111, 333-340
20. Sato, E., Shick, H. E., Ransohoff, R. M., and Hirose, K. (2010) Expression of fractalkine receptor CX3CR1 on cochlear macrophages influences survival of hair cells following ototoxic injury. J. Assoc. Res. Otolaryngol. 11, 223-234
21. Huang, D., Shi, F. D., Jung, S., Pien, G. C., Wang, J., Salazar-Mather, T. P., He, T. T., Weaver, J. T., Ljunggren, H. G., Biron, C. A., Littman, D. R., and Ransohoff, R. M. (2006) The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 20, 896-905
22. Cipriani, R., Villa, P., Chece, G., Lauro, C., Paladini, A., Micotti, E., Perego, C., De Simoni, M. G., Fredholm, B. B., Eusebi, F., and Limatola, C. (2011) CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J. Neurosci. 31, 16327-16335
23. Bhaskar, K., Konerth, M., Kokiko-Cochran, O. N., Cardona, A., Ransohoff, R. M., and Lamb, B. T. (2010) Regulation of tau pathology by the microglial fractalkine receptor. Neuron 68, 19-31
24. Cho, S. H., Sun, B., Zhou, Y., Kauppinen, T. M., Halabisky, B., Wes, P., Ransohoff, R. M., and Gan, L. (2011) CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J. Biol. Chem. 286, 32713-32722
25. Fuhrmann, M., Bittner, T., Jung, C. K. E., Burgold, S., Page, R. M., Mitteregger, G., Haass, C., LaFerla, F. M., Kretzschmar, H., and Herms, J. (2010) Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat. Neurosci. 13, 411-413
26. Lee, S., Varvel, N. H., Konerth, M. E., Xu, G., Cardona, A. E., Ransohoff, R. M., and Lamb, B. T. (2010) CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Am. J. Pathol. 177, 2549-2562
27. Liu, Z., Condello, C., Schain, A., Harb, R., and Grutzendler, J. (2010) CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-b phagocytosis. J. Neurosci. 30, 17091-17101
28. Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., Lee, J. C., Cook, D. N., Jung, S., Lira, S. A., Littman, D. R., and Ransohoff, R. M. (2006) Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9, 917-924
29. Poupel, L., Boissonnas, A., Hermand, P., Dorgham, K., Guyon, E., Auvynet, C., Charles, F. S., Lesnik, P., Deterre, P., and Combadiere, C. (2013) Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 33, 2297-2305
30. Ridderstad Wollberg, A., Ericsson-Dahlstrand, A., Juréus, A., Ekerot, P., Simon, S., Nilsson, M., Wiklund, S. J., Berg, A. L., Ferm, M., Sunnemark, D., and Johansson, R. (2014) Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis. Proc. Natl. Acad. Sci. USA 111, 5409-5414
31. McDermott, D. H., Fong, A. M., Yang, Q., Sechler, J. M., Cupples, L. A., Merrell, M. N., Wilson, P. W., D'Agostino, R. B., O'Donnell, C. J., Patel, D. D., and Murphy, P. M. (2003) Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J. Clin. Invest. 111, 1241-1250
32. Moatti, D., Faure, S., Fumeron, F., Amara, Mel.-W., Seknadji, P., McDermott, D. H., Debré, P., Aumont, M. C., Murphy, P. M., de Prost, D., and Combadière, C. (2001) Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97, 1925-1928
33. Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., and Littman, D. R. (2000) Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20, 4106-4114
34. Huang, P., Zhao, X. S., Fields, M., Ransohoff, R. M., and Zhou, L. (2009) Imatinib attenuates skeletal muscle dystrophy in mdx mice. FASEB J. 23, 2539-2548
35. Zhou, L., Rafael-Fortney, J. A., Huang, P., Zhao, X. S., Cheng, G., Zhou, X., Kaminski, H. J., Liu, L., and Ransohoff, R. M. (2008) Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice. J. Neurol. Sci. 264, 106-111
36. Ramachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Ali, A., Hartland, S. N., Snowdon, V. K., Cappon, A., Gordon-Walker, T. T., Williams, M. J., Dunbar, D. R., Manning, J. R., van Rooijen, N., Fallowfield, J. A., Forbes, S. J., and Iredale, J. P. (2012) Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc. Natl. Acad. Sci. USA 109, E3186-E3195
37. Megeney, L. A., Kablar, B., Garrett, K., Anderson, J. E., and Rudnicki, M. A. (1996) MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. 10, 1173-1183
38. Mokalled, M. H., Johnson, A. N., Creemers, E. E., and Olson, E. N. (2012) MASTR directs MyoD-dependent satellite cell differentiation during skeletal muscle regeneration. Genes Dev. 26, 190-202
39. Charo, I. F., and Ransohoff, R. M. (2006) The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354, 610-621
40. Varga, T., Mounier, R., Gogolak, P., Poliska, S., Chazaud, B., and Nagy, L. (2013) Tissue LyC6- macrophages are generated in the absence of circulating LyC6- monocytes and Nur77 in a model of muscle regeneration. J. Immunol. 191, 5695-5701
41. Blomster, L. V., Vukovic, J., Hendrickx, D. A., Jung, S., Harvey, A. R., Filgueira, L., and Ruitenberg, M. J. (2011) CX3CR1 deficiency exacerbates neuronal loss and impairs early regenerative responses in the target-ablated olfactory epithelium. Mol. Cell. Neurosci. 48, 236-245
42. Peiser, L., and Gordon, S. (2001) The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation. Microbes Infect. 3, 149-159
43. Devitt, A., Parker, K. G., Ogden, C. A., Oldreive, C., Clay, M. F., Melville, L. A., Bellamy, C. O., Lacy-Hulbert, A., Gangloff, S. C., Goyert, S. M., and Gregory, C. D. (2004) Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/- mice. J. Cell Biol. 167, 1161-1170
44. Dumont, N., and Frenette, J. (2010) Macrophages protect against muscle atrophy and promote muscle recovery in vivo and in vitro: a mechanism partly dependent on the insulin-like growth factor-1 signaling molecule. Am. J. Pathol. 176, 2228-2235
45. Heinemeier, K. M., Olesen, J. L., Haddad, F., Schjerling, P., Baldwin, K. M., and Kjaer, M. (2009) Effect of unloading followed by reloading on expression of collagen and related growth factors in rat tendon and muscle. J. Appl. Physiol. 106, 178-186
46. Pelosi, L., Giacinti, C., Nardis, C., Borsellino, G., Rizzuto, E., Nicoletti, C., Wannenes, F., Battistini, L., Rosenthal, N., Molinaro, M., and Musaro, A. (2007) Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. FASEB J. 21, 1393-1402
47. Summan, M., Warren, G. L., Mercer, R. R., Chapman, R., Hulderman, T., Van Rooijen, N., and Simeonova, P. P. (2006) Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R1488-R1495
48. Ueno, M., Fujita, Y., Tanaka, T., Nakamura, Y., Kikuta, J., Ishii, M., and Yamashita, T. (2013) Layer V cortical neurons require microglial support for survival during postnatal development. Nat. Neurosci. 16, 543-551
49. Begue, G., Douillard, A., Galbes, O., Rossano, B., Vernus, B., Candau, R., and Py, G. (2013) Early activation of rat skeletal muscle IL-6/STAT1/STAT3 dependent gene expression in resistance exercise linked to hypertrophy. PLoS One 8, e57141
50. Serrano, A. L., Baeza-Raja, B., Perdiguero, E., Jardí, M., and Muñoz-Cánoves, P. (2008) Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 7, 33-44
51. Zhang, C., Li, Y., Wu, Y., Wang, L., Wang, X., and Du, J. (2013) Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration. J. Biol. Chem. 288, 1489-1499